Skip to main content

Latest SEC Filings — Page 162

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

TuHURA Q2 2026: $1.0M Cash, $50M Credit Facility Draws, CEO 10b5-1 Plan
Form 10-QHURA · Form 10-Q · 2026-08-14
Lightwave Logic Q2 Loss Widens 33% as R&D Spend Jumps; Cash Runway Extended to Dec 2027
Form 10-QLWLG · Form 10-Q · 2026-08-14
PMV Pharma Flags Going Concern Doubt as Cash Drops to $79.4M
ProForm 10-QPMVP · Form 10-Q · 2026-08-14
CCSC Seeks Shareholder Approval for 20:1 Reverse Split, 20x Authorized Share Increase, and $50M Asset Acquisition Authority
ProForm 6-KCCTG · Form 6-K · 2026-08-14
Sigma Lithium Q2 2026: Record Revenue and EBITDA, But Material Weaknesses and Going Concern Flagged
ProForm 6-KSGML · Form 6-K · 2026-08-14
LanzaTech Q2: $208M SGLT Gain Masks Operating Loss; Material Weaknesses Persist
ProForm 10-QLNZA · Form 10-Q · 2026-08-14
AirJoule Q2 10-Q Reveals Material Weakness and Insider 10b5-1 Plans
ProForm 10-QAIRJ · Form 10-Q · 2026-08-14
Galectin Reports Q2 Loss of $9.2M, FDA Agreement on Phase 3 Design, and Cash Runway to June 2027
Form 8-KGALT · Form 8-K · 2026-08-14
LanzaTech Q2: $184M Net Income on SGLT Gain, Reintroduces FY26 Guidance
ProForm 8-KLNZA · Form 8-K · 2026-08-14
HawkEye 360 10-Q Reveals Material Weaknesses and Insider Selling Plans
ProForm 10-QHAWK · Form 10-Q · 2026-08-14
Edible Garden Q2 Revenue Up 12.8% to $3.6M, Loss Narrows; RTD Prototype Completed
Form 8-KEDBL · Form 8-K · 2026-08-14
NexPoint Faces $136M Cityplace Debt Maturity with No Assurance of Extension
ProForm 10-QNXDT · Form 10-Q · 2026-08-14
GRI Bio's Q2 Loss, Going Concern Doubt, and Nasdaq Delisting Risk
ProForm 10-QGRI · Form 10-Q · 2026-08-14
Helus Pharma Q1 FY2027: $47.8M Net Loss, $166.4M Cash, Phase 3 Data on Track for Q4
Form 6-KHELP · Form 6-K · 2026-08-14
Western Union Secures NYDFS Approval for Intermex Deal, But California Suspension Clouds Timeline
Form 8-KWU · Form 8-K · 2026-08-14
PLDT Clarifies Auditor Opinion Stands on Philippine Filings; VP Departs Under Manpower Reduction
Form 6-KPHI · Form 6-K · 2026-08-14
AstroNova Faces Shareholder Lawsuits Over Merger Proxy Disclosures
Form DEFA14AALOT · Form DEFA14A · 2026-08-14
Lantern Pharma Q2 2026: LP-300 PFS Deepens, EMA Clears LP-184, OMAI Spin-Off Formalized
ProForm 8-KLTRN · Form 8-K · 2026-08-14
Braskem 2Q26: EBITDA Soars to $1B, But Default and D-Rating Loom
ProForm 6-KBAK · Form 6-K · 2026-08-14
Beneficient Q1 FY2027: First Collateral Deal, $16M New Capital, Sharp Cost Cuts
Form 8-KBENF · Form 8-K · 2026-08-14
Teamshares 10-Q Flags Going Concern Risk with $187.8M Debt Maturity
ProForm 10-QTMS · Form 10-Q · 2026-08-14
Lantern Pharma Q2 2026: Going Concern Warning, $7.5M Warrant Liability, and Open Medicine AI Spin-Off
ProForm 10-QLTRN · Form 10-Q · 2026-08-14
ZW Data Action Technologies Flags Going Concern as Q2 Loss Widens
ProForm 10-QCNET · Form 10-Q · 2026-08-14
Going Concern Doubt Lifted as Creative Realities Posts Q2 Turnaround and Completes Offering
ProForm 10-QCREX · Form 10-Q · 2026-08-14
Digi Power X Reports First AI Compute Revenue, $1.1B Contracted Backlog, and Positive Adjusted EBITDA
ProForm 8-KDGXX · Form 8-K · 2026-08-14
Mako Mining Posts Record Q2 2026: $31.7M Adjusted EBITDA, $0.16 EPS
ProForm 6-KMAKO · Form 6-K · 2026-08-14
Neumora Flags Going Concern Doubt as Cash Runs Short
ProForm 10-QNMRA · Form 10-Q · 2026-08-14
Adlai Nortye's H1 2026 results show a strengthened balance sheet with $231.9M in cash, a reduced net loss of $5.3M, and pipeline milestones on track.
Form 6-KANL · Form 6-K · 2026-08-14
Neumora Names Joshua Pinto CEO as Berns Moves to Executive Chair
Form 8-KNMRA · Form 8-K · 2026-08-14
Tvardi Q2 10-Q: Going Concern Warning and Material Weaknesses Persist
ProForm 10-QTVRD · Form 10-Q · 2026-08-14